| Product Name | MF | CAS | Details |
|---|
| LCZ696（valsartan + sacubitril） Impurity 14 | C22H23NO4 | 1639970-62-9 | Details |
| LCZ696（valsartan + sacubitril） impurity 23 | C20H23NO3 | 149709-58-0 | Details |
| lansoprazole impurity 2 | C16H14F3N3O4S | 953787-54-7 | Details |
| lansoprazole EP impurity B | C16H14F3N3O3S | 131926-99-3 | Details |
| (R)-Amlodipine | C17H28N5O7P | 1246812-40-7 | Details |
| Sacubitril (Calcium Salt) | C48H56CaN2O10 | 1369773-39-6 | Details |
| LCZ696 | C23H29NO4 | 1012341-52-4 | Details |
| Dexmedetomidine Impurity 15 | C12H15ClN2 | 90038-01-0 | Details |
| LCZ696(valsartan + sacubitril) impurity 9 | C24H27NO4 | 1038924-97-8 | Details |
| Cilnidipine Impurity 10 | C24H29NO5 | 149709-62-6 | Details |
| Ivabradine related compound 7 | C15H21NO4 | 1235547-07-5 | Details |
| LCZ696（valsartan + sacubitril） impurity 20 | C23H29NO4 | 1012341-56-8 | Details |
| LCZ696（valsartan + sacubitril） Impurity 11 | C25H33NO4 | 149709-60-4 | Details |
| Ivabradine related compound 9 | C12H13NO4 | 85175-49-1 | Details |
| Mono-POC Methyl Tenofovir | C15H24N5O7P | 1246812-16-7 | Details |
| Ivabradine related compound | 1332667-04-9 | Details |
| LCZ696（valsartan + sacubitril） impurity 25 | C20H25NO2 | 752174-62-2 | Details |
| LCZ696（valsartan + sacubitril） Impurity 10 | C18H22ClNO2 | 1038924-71-8 | Details |
| LCZ696(valsartan + sacubitril) impurity 19 | C23H29NO4 | 1012341-54-6 | Details |
| LCZ696（valsartan + sacubitril） impurity 24 | C25H31NO4 | 149709-59-1 | Details |
| C20H26O2 | 848-04-4 | Details |
| Baricitinib Impurity I | C16H26N5O7P | 1796539-92-8 | Details |
| Mono-POC Tenofovir (Mixture of Diastereomers) | C14H22N5O7P | 211364-69-1 | Details |
| Ivabradine related compound 4 | C15H18ClNO3 | 85175-59-3 | Details |
| Ivabradine IMpurity 8 | C15H20ClNO3 | Details |
| Ivabradine related compound 5 | C15H19NO4 | 1235547-06-4 | Details |
| Ivabradine related compound 6 | C10H12O4 | 93-40-3 | Details |
| Levofloxacin ImpurityABCDE | C16H18FN3O4 | 151250-76-9 | Details |
| Medetomidine Impurity 2 | C10H13Cl | 60907-88-2 | Details |
| Medetomidine Impurity 11 | C14H18N2 | 86347-62-8 | Details |
| Medetomidine Impurity 3 | C10H13Cl | 104245-83-2 | Details |
| Lamivudine EP lmpurity B(2S，5S-Isomer) | C8H11N3O3S | 136846-20-3 | Details |
| L-Pyroglutamic acid | C5H7NO3 | 98-79-3 | Details |
| Ezetimibe (SSR)-Isomer | C4H11ClN2O | 7682-20-4 | Details |
| Levetiracetam EP Impurity C | C5H5NO | 142-08-5 | Details |
| Levetiracetam Impurity K | C4H7ClO2 | 627-00-9 | Details |
| Levetiracetam Impurity H | C4H9NO2 | 1492-24-6 | Details |
| Linagliptin Impurity D | C20H28N6O4 | 666816-91-7 | Details |
| Linagliptin Impurity K | C25H29BrN8O2 | Details |
| Linagliptin Impurity E | C25H28N8O2 | 668273-75-3 | Details |
| Linagliptin Impurity G | C25H28N8O2 | 668270-11-9 | Details |
| Ivabradine related compound 1 | C11H15NO2 | 73344-75-9 | Details |
| Medetomidine Impurity 14 | C12H17ClN2O | 90038-00-9 | Details |
| Medetomidine Impurity 15 | C13H16N2O | 86347-12-8 | Details |
| N-Nitroso Furosemide | C18H20FN3O5 | 117678-38-3 | Details |
| Linagliptin Impurity F | C27H27F3N8O3 | 1673546-62-7 | Details |
| Medetomidine Impurity 8 | C10H12 | 40243-75-2 | Details |
| Medetomidine Impurity 5 | C10H14O | 33967-19-0 | Details |
| Medetomidine Impurity 16 | C11H16O | 944268-64-8 | Details |
| Levomedetomidine HCl | C13H17ClN2 | 190000-46-5 | Details |
| Medetomidine Impurity 12 | C12H14N2 | 76631-46-4 | Details |
| Ivabradine related compound 2 | C14H21NO5 | 73954-34-4 | Details |
| Linagliptin Impurity CD10139 | C20H22FN3O4 | 721970-36-1 | Details |
| Moxifloxacin EP Impurity B | C22H27N3O5 | 1029364-73-5 | Details |
| Linagliptin Impurity CD10118 | C18H19NO | 1038924-70-7 | Details |
| Moxifloxacin EP Impurity C | C22H26FN3O4 | 1029364-75-7 | Details |
| Losartan potassium impurity A | C8H11ClN2O | 83857-96-9 | Details |
| Levofloxacin Impurity 10 | C13H9F2NO4 | 110548-07-7 | Details |
| Levofloxacin Impurity 11 | C15H13F2NO4 | 106939-34-8 | Details |
| Levofloxacin Impurity A | C17H18FN3O4 | 117707-40-1 | Details |
| Levofloxacin diformy Impurity 14 | C18H18FN3O6 | 151377-74-1 | Details |
| Levofloxacin Impurity 14 | C15H15F4NO4 | 110548-02-2 | Details |
| Levofloacin Impurity 16 | C18H22FN3O5 | 138199-71-0 | Details |
| Levofloxacin Diamine Impurity 15 | C15H16FN3O4 | 1797510-34-9 | Details |
| Cilnidipine Impurity 18 | C20H26ClNO2 | 149690-12-0 | Details |
| lansoprazole impurity 1 | C25H22F6N4O2S | 1083100-27-9 | Details |
| L-4-Thiazolidinecarboxylic acid | C4H7NO2S | 34592-47-7 | Details |
| Moxifloxacin EP Impurity D | C21H24FN3O4 | 1029364-77-9 | Details |
| Ivabradine Impurity 10（free base） | C27H38N2O6 | 1462470-54-7 | Details |
| Moxifloxacin EP Impurity A | C20H21F2N3O3 | 151213-15-9 | Details |
| Levofloxacin carboxylic acid | C13H9F2NO4 | 100986-89-8 | Details |
| Levofloxacin Related Compound E HCl | C16H19ClFN3O4 | 1346603-62-0 | Details |
| Levofloxacin Impurity | C20H24FN3O4 | 177472-30-9 | Details |
| Levofloxacin Impurity D | C18H21N3O4 | 117620-85-6 | Details |
| Linagliptin Impurity B | C30H36N8O4 | 668273-75-4 | Details |
| Linezolid Impurity 1 | C3H9Cl2NO | 54798-73-1 | Details |
| Linezolid Impurity 4 | C14H17FN2O4 | 168828-82-8 | Details |
| Latanoprost Related Compound E | C23H34O5 | 41639-83-2 | Details |
| Linezolid Impurity 3 | C10H11BrN2O3 | 477846-96-1 | Details |
| Linezolid Impurity 7 | C10H13FN2O | 1175797-88-2 | Details |
| Linezolid Impurity 2 | C3H8ClNO | 725676-93-7 | Details |
| Linezolid Impurity 5 | C16H20FN3O5 | 189038-36-6 | Details |
| lansoprazole EP impurity A | C16H14F3N3O3S | 213476-12-1 | Details |
| Noradrenaline Impurity 50 | C22H26FN3O4 | 721970-37-2 | Details |
| 2-(((3-methyl-4-(2,2,2-trifluoroethoxy) | C16H14F3N3OS | 103577-40-8 | Details |
| Levofloxacin Impurity 9 | C15H13F2NO4 | 110548-06-6 | Details |
| (S)-9,10-difluoro-3-methyl | C13H11F2NO4 | 1026952-91-9 | Details |
| Levofloxacin Impurity 7 | C15H14FNO4 | 431058-46-7 | Details |
| Vitamin B6 Impurity 58 | C18H20FN3O4 | 178912-62-4 | Details |
| Levofloxacin Impurity 8 | C13H10FNO4 | 117620-84-5 | Details |
| N-Nitroso Furosemide | C17H20FN3O2 | 178964-53-9 | Details |
| Levofloxacin Impurity E | C18H20FN3O4 | 100986-86-5 | Details |
| Levetiracetam USP Related Compound A | C8H15ClN2O2 | 102767-31-7 | Details |
| Levetiracetam EP Impurity B | C8H12N2O2 | 358629-47-7 | Details |
| methyl (S)-2-aminobutanoate hydrochloride | C5H11NO2 | 15399-22-1 | Details |
| Brivaracetam Impurity 27 | C4H11ClN2O | 103765-03-3 | Details |
| Levetiracetam EP Impurity D | C8H14N2O2 | 103765-01-1 | Details |
| Levetiracetam EP Impurity A | C8H13NO3 | 67118-31-4 | Details |
| 2-hydroxy-50-(methylthio)butanamide | C7H6N2S | 583-39-1 | Details |
| lansoprazole EP impurity F | C14H12ClN3OS | 168167-42-8 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 | ||||